Ironwood Pharmaceuticals, Inc. (IRWD) Stock Overview
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It sells linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults…
Source: Yahoo Finance
Sector & Industry
Ironwood Pharmaceuticals, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the NASDAQ exchange.
Ironwood Pharmaceuticals, Inc. at a Glance
| Company | Ironwood Pharmaceuticals, Inc. |
| Ticker | IRWD |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $4.26 |
| Market cap | $703.92M |
| P/E ratio (trailing) | 5.39 |
| EPS (trailing) | $0.79 |
| 52-week high | $5.78 |
| 52-week low | $1.05 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.21 |
| Return on equity (ROE) | — |
| Debt-to-equity | — |
| Average volume | 2.20M |
| Shares outstanding | 165.24M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 100 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Ironwood Pharmaceuticals, Inc.'s current P/E ratio?
- Ironwood Pharmaceuticals, Inc. (IRWD) has a trailing P/E ratio of 5.39 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Ironwood Pharmaceuticals, Inc.'s market capitalisation?
- Ironwood Pharmaceuticals, Inc.'s market cap is $703.92M based on our latest snapshot. See how it ranks by market cap →
- What is IRWD's 52-week range?
- Over the past 52 weeks, IRWD has traded between $1.05 and $5.78. What does the 52-week range mean? →
- How volatile is Ironwood Pharmaceuticals, Inc. compared to the market?
- Ironwood Pharmaceuticals, Inc. has a beta of 0.21, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Ironwood Pharmaceuticals, Inc. pay a dividend?
- Ironwood Pharmaceuticals, Inc. does not currently pay a dividend according to our latest data.
- What exchange is IRWD listed on?
- IRWD is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Ironwood Pharmaceuticals, Inc. in?
- Ironwood Pharmaceuticals, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →